OCC.AX ASX
Orthocell Limited
1W: +2.7%
1M: +4.8%
3M: -12.6%
YTD: -24.0%
1Y: -33.3%
3Y: +114.1%
5Y: +60.0%
A$0.74 ($0.52)
-0.02 (-2.61%)
Weekly Expected Move ±6.5%
A$1
A$1
A$1
A$1
A$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$11M
+51.1% ▲
5Y CAGR: +62.1%
Gross Profit
$4M
-23.5% ▼
5Y CAGR: +65.1%
Operating Income
-$18M
-31.5% ▼
Net Income
-$14M
-62.4% ▼
EPS (Diluted)
$-0.05
-37.5% ▼
EBITDA
-$18M
-30.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $2M | $4M | $5M | $8M | $11M |
| YoY Growth | +50.5% | +177.0% | +25.3% | +42.1% | +51.1% |
| Cost of Revenue | $699K | $1M | $2M | $3M | $8M |
| Gross Profit | $833K | $3M | $4M | $5M | $4M |
| Gross Margin | 54.4% | 72.1% | 69.4% | 63.6% | 32.2% |
| R&D Expenses | $7M | $8M | $9M | $9M | $4M |
| SG&A Expenses | $6M | $6M | $7M | $9M | $18M |
| Operating Expenses | $12M | $13M | $15M | $19M | $22M |
| Operating Income | -$12M | -$10M | -$12M | -$14M | -$18M |
| Operating Margin | -752.4% | -243.0% | -219.8% | -185.1% | -161.2% |
| Interest Expense | $0 | $0 | $61K | $0 | $0 |
| Income Before Tax | -$11M | -$9M | -$10M | -$12M | -$14M |
| Tax Expense | -$2M | -$3M | -$3M | -$3M | $0 |
| Net Income | -$9M | -$6M | -$7M | -$9M | -$14M |
| Net Margin | -594.5% | -147.3% | -135.1% | -113.5% | -122.0% |
| EPS (Diluted) | $-0.05 | $-0.03 | $-0.04 | $-0.04 | $-0.05 |
| EBITDA | -$12M | -$10M | -$12M | -$13M | -$18M |
| Shares Outstanding | 195M | 197M | 202M | 223M | 263M |